Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.37 USD | +0.61% | -11.95% | -81.03% |
Mar. 28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M | MT |
Financials (USD)
Sales 2024 * | 36.84M | Sales 2025 * | 50.93M | Capitalization | 2.54M |
---|---|---|---|---|---|
Net income 2024 * | 5M | Net income 2025 * | 13M | EV / Sales 2024 * | 0.07 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.05 x |
P/E ratio 2024 * |
0.47
x | P/E ratio 2025 * |
0.34
x | Employees | 19 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.56% |
Latest transcript on Agile Therapeutics, Inc.
1 day | +0.61% | ||
1 week | -11.95% | ||
Current month | +8.82% | ||
1 month | -33.93% | ||
3 months | -76.58% | ||
6 months | -79.33% | ||
Current year | -81.03% |
Managers | Title | Age | Since |
---|---|---|---|
Al Altomari
CEO | Chief Executive Officer | 65 | 04-01-31 |
Scott Coiante
DFI | Director of Finance/CFO | 57 | 10-11-30 |
Paul Korner
CTO | Chief Tech/Sci/R&D Officer | 58 | 20-08-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Al Altomari
CEO | Chief Executive Officer | 65 | 04-01-31 |
Seth Fischer
BRD | Director/Board Member | 68 | 16-07-27 |
John Hubbard
BRD | Director/Board Member | 67 | 14-11-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 0.37 | +0.61% | 15,137 |
24-04-17 | 0.3678 | -4.62% | 119,671 |
24-04-16 | 0.3856 | +4.10% | 123,040 |
24-04-15 | 0.3704 | +1.74% | 35,158 |
24-04-12 | 0.364 | -13.35% | 78,790 |
Delayed Quote OTC Markets, April 18, 2024 at 03:56 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.03% | 2.52M | |
-3.30% | 102B | |
+1.79% | 96.84B | |
-0.44% | 21.48B | |
-18.35% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.84% | 13.78B | |
+0.59% | 13.4B | |
+20.86% | 11.06B |
- Stock Market
- Equities
- AGRX Stock